Group 1: Financial Policies in Shanghai - The People's Bank of China announced 8 financial policy measures to be implemented in Shanghai, including the establishment of an interbank market trading report database and a digital RMB international operation center [1] - The policies aim to support offshore trade, enhance cross-border trade and investment facilitation, and promote structural monetary policy innovation [1] - The National Financial Regulatory Administration and Shanghai government jointly released an action plan to support the construction of Shanghai as an international financial center, focusing on risk management and legal construction in finance [1] Group 2: Reforms in the Sci-Tech Innovation Board - The China Securities Regulatory Commission (CSRC) announced the establishment of a Sci-Tech Growth Tier on the Sci-Tech Innovation Board, allowing unprofitable companies to apply for listing under the fifth set of standards [2] - Six reform measures were introduced, including the introduction of professional institutional investors and a pre-review mechanism for IPOs of quality tech companies [2] - The CSRC emphasized the protection of small and medium investors' rights, requiring companies to disclose reasons for unprofitability and associated risks [2] Group 3: Supportive Policies from the State Administration of Foreign Exchange - The State Administration of Foreign Exchange introduced multiple supportive policies to stabilize employment, enterprises, and market expectations, encouraging banks to include more trade entities in facilitation policies [3] - Policies aim to enhance cross-border investment and financing convenience, including support for research institutions to attract foreign investment and streamline capital project management [3] - A new batch of Qualified Domestic Institutional Investor (QDII) investment quotas will be issued to meet the reasonable overseas investment needs of domestic entities [3]

Core Viewpoint - The introduction of the "1+6" policy by the China Securities Regulatory Commission (CSRC) aims to facilitate the listing of loss-making companies on the Sci-Tech Innovation Board (STAR Market), addressing the challenges faced by tech firms in securing funding and going public [2][4]. Group 1: Policy Overview - The "1+6" policy includes the establishment of a Sci-Tech Growth Layer on the STAR Market, allowing companies with losses or zero revenue to list [2][4]. - Currently, there are 30 companies marked with a "U" indicating they are in the Sci-Tech Growth Layer, which allows for listing despite losses [4]. - New regulations require companies registered after the new rules to meet stricter criteria to remove the "U" mark, compared to previous standards [6]. Group 2: Listing Standards - The first standard for listing requires companies to be profitable in the last two years with a total profit of at least 50 million yuan, or to have a profit and revenue of at least 100 million yuan in the last year [7]. - The fifth standard allows companies with losses and zero revenue to list, provided they have a market value of over 4 billion yuan and meet other specific criteria [9][10]. - Currently, 20 companies have utilized the fifth standard for listing, primarily in the biopharmaceutical sector [12][13]. Group 3: New Measures - The policy introduces six reform measures, including expanding the fifth standard to support more frontier technology sectors like artificial intelligence and commercial aerospace [8][17]. - A new mechanism for pre-IPO review is being piloted to protect sensitive information for high-quality tech companies [22][23]. - Companies can now raise funds from existing shareholders during the IPO process, which is beneficial for those lacking self-sustaining financial capabilities [24][25]. Group 4: Investment and Oversight - The introduction of a system for professional institutional investors aims to enhance the evaluation of companies that qualify for the fifth standard, ensuring better judgment on their future prospects [19][20]. - The CSRC emphasizes the need for strict regulatory measures to prevent fraudulent activities and protect investor rights, ensuring that companies meet multiple criteria for listing [28].

21世纪经济报道记者 易妍君 广州报道 6月18日，中国证监会主席吴清在2025陆家嘴论坛上宣布，将推出进一步深化科创板改革的"1+6"政策措 施。 科创板改革"1+6"政策措施涉及：设置科创板成长层；重启未盈利企业适用科创板第五套标准上市；试 点引入资深专业机构投资者制度；扩大第五套标准适用范围等内容。 同时，吴清提到，证监会将进一步强化股债联动服务科技创新的优势；更大力度培育壮大耐心资本、长 期资本；支持科技型上市公司做优做强；构建更加开放包容的资本市场生态。 此外，围绕金融开放以及人民币国际化，中国人民银行亦释放了资本市场制度红利。 徐飞指出，科技创新是引领经济高质量发展的排头兵，新政策措施加强科技创新和金融"五篇大文章"的 有效协同，充分发挥资本市场的枢纽功能，促进科技、资本、产业良性循环，加大对处在不同生命周期 阶段科技创新企业的支持力度，有助于形成多元化、多层次、多渠道的支持科技企业发展的资本市场生 态，促进我国科技企业做大做强。 从细节来看，财通策略李美岑团队指出，板块分层一方面有利于投资者分辨企业风险和成长性、起到保 护作用，另一方面也能降低未盈利企业入市的阻碍、支持新兴企业融资。同时，IPO ...

科创50指数今日下跌0.54%，报收962.94点，科创板全日成交量26.69亿股，成交额896.96亿元，加权平 均换手率为1.55%。 从杠杆资金动向看，高换手个股中，共43股近期获杠杆资金净买入，统计显示，截至6月18日，近5日融 资余额增加较多的有有方科技、仕佳光子、荣昌生物等，分别增加1.22亿元、9066.65万元、7301.73万 元；融资余额减少金额较多的有影石创新、中邮科技、德科立等，分别减少1.66亿元、7910.20万元、 3030.09万元。 6月19日科创板换手率居前个股 | 代码 | 简称 | 最新收盘价 | 日涨跌幅（%） | 日换手率（%） | 资金净流入（万元） | | --- | --- | --- | --- | --- | --- | | 688291 | 金橙子 | 35.92 | 5.90 | 40.37 | 3242.98 | | 688573 | 信宇人 | 27.70 | -4.15 | 29.63 | -1422.93 | | 688775 | 影石创新 | 178.40 | -12.64 | 27.60 | -17354.50 | | 688203 | 海 ...

投资策略 +-[Table_MainInfo]科创板改革获推进，市场延续窄幅震荡 ――A 股市场投资策略周报 | 分析师： 严佩佩 | | SAC NO： | S1150520110001 2025 年 6 月 19 日 | | | | | --- | --- | --- | --- | --- | --- | --- | | [Table_Analysis] 证券分析师 | [Table_Summary] 投资要点： | | | | | | | 严佩佩 |  | 市场回顾，近 | 个交易日（6 月 日-6 月 日），重要指数纷纷收跌； 13 19 | | | 5 | | 022-23839070 | | 其中，上证综指收跌 | 1.19%，创业板指收跌 1.95%；风格层面，沪深 | 300 | | | | SAC NO:S1150520110001 | 收跌 | 1.26%，中证 | 收跌 2.12%。成交量方面小幅缩量，两市统计区 | | 500 | | | yanpp@bhzq.com | 间内成交 | 6.33 | 万亿元，日均成交额达到 万亿元，较前五个交易日 1.27 | | | | | | ...

文/《清华金融评论》 王茅 就在昨天（ 6月18日），证监会发布了一条重磅政策——制定了 《科创 板意见》， 若能够顺利实施，将在很大程度上解决A股长期以来面临的一 个"痛点"，那就是具有潜力，但尚未实现盈利的科技公司不得已到香港、 美国上市的情况。这个问题如果得到解决，A股未来也将诞生自己的高科 技"独角兽"，值得期待。 长期以来，不少硬科技公司、有成长性的公司，往往选择赴香港、美国上市，原因在于以前A股没有可 以让这些公司上市的合适路径与渠道，这些公司有个硬伤——尚未实现盈利。 证监会制定《科创板意见》，为尚未盈利的硬科技公司上市打开一扇门 证监会制定了《关于在科创板设置科创成长层增强制度包容性适应性的意见》（以下简称《科创板意 见》），为尚未实现盈利的硬科技公司的上市打开了一扇门。 《科创板意见》里，最关键的就是设置科创成长层，允许那些还没有实现盈利，但是已实现技术突破， 同时研发投入高、商业前景广阔的硬科技公司先"上市"。 科技是第一生产力，虽然科技公司前景广阔，但天然带有风险性。科技的变化可以说是日新月异，如果 上市了，最终又没能实现盈利，被淘汰出局，这将是普通投资者无法承受之重。这就是A股一直以来 ...

金融界6月19日消息，上证指数低开低走，上证科创板高端装备制造指数(科创高装，000687)下跌 0.55%，报993.99点，成交额103.5亿元。 数据统计显示，上证科创板高端装备制造指数近一个月下跌2.41%，近三个月下跌11.55%，年至今上涨 4.77%。 据了解，上证科创板高端装备制造指数从科创板市场中选取50只市值较大的航空装备、卫星及应用、轨 道交通装备、海洋工程装备、智能制造装备等领域上市公司证券作为指数样本，反映科创板市场代表性 高端装备制造产业上市公司证券的整体表现。该指数以2019年12月31日为基日，以1000.0点为基点。 从指数持仓来看，上证科创板高端装备制造指数十大权重分别为：中微公司（9.78%）、九号公司 （9.25%）、石头科技（8.59%）、柏楚电子（4.51%）、道通科技（3.96%）、绿的谐波（3.71%）、中 国通号（3.65%）、铂力特（3.52%）、时代电气（3.05%）、中无人机（2.84%）。 从上证科创板高端装备制造指数持仓的市场板块来看，上海证券交易所占比100.00%。 从上证科创板高端装备制造指数持仓样本的行业来看，工业占比70.71%、可选消费占 ...

·科创板"U"标企业来了！未盈利公司专属"成长层"必看5大要点科创板科创成长层，横空出世。科创成 长层将成为未盈利企业的聚集地——科创板存量、增量未盈利企业，全部转移至科创板创新层。关于科 创成长层，五大要点值得关注。详情>> ·瑞银万亿资管版图迎"掌舵人"！28年老将吴家耀空降亚太区21世纪经济报道记者从瑞银证券处获悉， 瑞银集团(UBS)近日完成关键人事布局——吴家耀将于10月1日正式出任瑞银资产管理亚太区主管，这 一任命被视为瑞银完成收购瑞信后强化亚太战略的重要落子。详情>> ·十五运会规模创纪录，粤港澳办赛"心联通"今年，十五运会和残特奥会将在粤港澳三地举办。6月18 日，十五运会和残特奥会筹备工作进展情况介绍新闻发布会举行。会上介绍，赛事的项目设置将充分发 挥港澳办赛优势，赛事元素将彰显粤港澳大湾区的特色文化，促进三地互联互通。详情>> ·4000亿天量资金看好，"酱油茅"股价意外破发6月19日，"酱油一哥"海天味业（03288.HK）正式登陆港 股。上市首日，海天味业盘初一度上涨近5%，但随后股价回落跌破发行价。截至14时4分，海天味业港 股微涨0.14%，A股则跌3.73%。详情>> BAT和张 ...

【博时市场点评6月19日】风险偏好收敛，沪深两市调整 6月19日，A股三大指数下跌。截至收盘，上证指数报3362.11点，下跌0.79%；深证成指报10051.97点， 下跌1.21%；创业板指报2026.82点，下跌1.36%；科创100报1022.12点，下跌0.46%。申万一级行业中， 仅石油石化上涨，涨幅为0.86%；纺织服饰、美容护理、轻工制造跌幅靠前，分别下跌2.36%、2.28%、 1.96%。699只个股上涨，4471只个股下跌。 简评：通过深化科创板改革"1+6"政策措施，重启未盈利企业适用科创板第五套标准上市，未盈利的优 质企业可在成长层渡过研发高风险期，盈利达标后转至科创板主层或主板，从而对科创企业形成全生命 周期的资本市场多层次支持链条，有助于提振科创企业发展信心，避免优质企业因盈利门槛外流，促进 资本市场各板块良性互动。 美联储公布6月利率决议，将基准利率维持在4.25%-4.50%不变，连续第四次会议按兵不动，符合市场预 期。美联储表示，对前景的不确定性已减弱，但仍然处于较高水平。美联储将2025年GDP预估下调至 1.4%，同时将通胀预期上调至3%。另外，美联储点阵图显示，202 ...

Core Viewpoint - The enthusiasm of investors in the pharmaceutical primary market has been reignited due to the China Securities Regulatory Commission's announcement of the "1+6" policy measures, which will support unprofitable innovative companies in listing on the Sci-Tech Innovation Board (STAR Market) [1][9]. Group 1: Policy Changes - The introduction of the "new fifth set" listing standards aims to provide a differentiated listing channel for innovative companies that are in the high R&D investment phase but have not yet achieved stable revenue [3][4]. - The "1" in the "1+6" policy refers to the establishment of a Sci-Tech Growth Layer on the STAR Market, which will include all existing and newly registered unprofitable technology companies [3]. - The fifth set of standards will expand its applicability beyond biomedicine to include sectors such as artificial intelligence, commercial aerospace, and low-altitude economy [7]. Group 2: Market Impact - The previous tightening of the STAR Market and the discounting of Hong Kong IPOs led to a significant reduction in investment activity in the pharmaceutical sector, but the reintroduction of the fifth set of standards is expected to enhance investment willingness and risk appetite in the primary market [1][2]. - Since the STAR Market's inception, 20 innovative biopharmaceutical companies have utilized the fifth set of standards for fundraising, with the total investment amount in the biopharmaceutical sector reaching a peak of $34 billion in 2021 [8]. - In 2022, the total investment in the domestic pharmaceutical industry dropped to $15.6 billion, halving compared to the previous year, and further decreased to $10.9 billion in 2023, marking a 30% year-on-year decline [8]. Group 3: Investor Sentiment - The new policies are expected to restore key listing channels for unprofitable pharmaceutical companies, thereby boosting investor confidence and attracting social capital into the biopharmaceutical sector [9]. - There are concerns about potential overheating in the market due to the execution of these policies and the resonance with market sentiment, which could lead to high valuations or share price declines for some unprofitable technology companies post-listing [9].